Dostar LB 100 study
JavaScript is disabled in your browser. Please enable JavaScript for a better experience.
Homepage
New Home
$event.target.closest('button').nextElementSibling.querySelector('.oxy-site-navigation__mobile-close-wrapper > button').focus() )" aria-label="Open navigation menu" :aria-expanded="rootOpen" x-ref="openButton">
$refs.openButton.focus() )" x-init="menu = [];" x-data="{ useCtaStyles: 'false', howManyCtas: '1' }">
Safety and efficacy of targeting PP2A in ovarian clear cell carcinoma using Dostarlimab and LB-100
Study Details
Find more information here
If you or someone you know is battling ovarian cancer, discover how Dostarlimab can be an effective treatment option
Study Details
Interested in participating in the study?
Send us an e-mail
close
chevron-down
bars